MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$9,605K
EPS
-$0.05
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2025-12-31
2025-09-30
2025-06-30
General and administrative
-
3,449*
2,867
3,002
Research and development
6,272
3,892*
4,216
3,871
General and administrative
4,357
-
-
-
Total operating expenses
10,629
7,340
7,083
6,873
Loss from operations
-10,629
-7,340*
-7,083
-6,873
Interest income
1,024
565
292
272
Total non-operating income
1,024
565*
292
272
Net loss
-9,605
-6,775
-6,791
-6,601
Basic EPS
-0.05
-0.056
-0.06
-0.07
Diluted EPS
-0.05
-0.056
-0.06
-0.07
Basic Average Shares
189,183,620
120,198,818
108,396,260
98,558,567
Diluted Average Shares
189,183,620
120,198,818
108,396,260
98,558,567
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Interest income
$1,024K
(276.47%↑ Y/Y)
Net loss
-$9,605K
(-45.51%↓ Y/Y)
Total non-operating
income
$1,024K
(276.47%↑ Y/Y)
Loss from operations
-$10,629K
(-54.65%↓ Y/Y)
Total operating
expenses
$10,629K
(54.65%↑ Y/Y)
Research and development
$6,272K
(62.03%↑ Y/Y)
General and
administrative
$4,357K
(45.14%↑ Y/Y)
Buy us a coffee
SELLAS Life Sciences Group, Inc. (SLS)
SELLAS Life Sciences Group, Inc. (SLS)